[Test] Blood Spot Screening

Drawing of a baby's foot with a Band-Aid on the heel, to indicate a blood spot screening test.

Overview

Blood spot screening uses a few drops of blood from the baby’s heel to check for serious, but treatable, health conditions. This screening is sometimes called a “heel stick” and takes place soon after birth. 

What to Expect

Blood spot screening usually happens 24-48 hours after birth, before the baby leaves the hospital. To take the blood spot screening, a health care provider will 

  • Gently warm the baby’s foot to increase blood flow
  • Make a quick pinprick on the baby’s heel
  • Collect a few small drops of blood onto a screening card

Once the blood spots have dried, the health care provider will send the card to the North Carolina State Laboratory of Public Health (State Laboratory). The state laboratory will run a series of tests to look for signs of serious, but treatable, conditions. 

Results

When and How You Get the Results

Parents: Your baby’s results are usually available within a few days after the sample arrives at the state laboratory. Your baby’s health care provider will receive the results.

Providers: Health care providers can access lab results in the North Carolina State Laboratory’s Clinical and Environmental Lab Results (CELR) system.

Understand what the Results mean

There are four possible screening results for the baby’s blood spot screening:

Normal

The baby’s results were within the normal ranges, also known as a “screen-negative” result.  

The baby does not need any further testing. 

Abnormal

 The baby’s result is not within normal ranges, also known as a “screen-positive” result.  

This result means that a baby may be at higher risk of having a condition. The baby will need additional testing. 

Borderline

The baby’s result is unclear. This means the baby needs another blood spot for more testing.  

A health care provider will need to collect a new blood spot specimen from the baby. The sState lLaboratory will test it again to get clearer results.   

Unsatisfactory

This means that the laboratory cannot report accurate results for a blood spot specimen due to how it was collected or handled. This does not mean there is a health problem. It means the blood spot could not be used for testing.  

This can happen for many reasons including blood spots that are contaminated, damaged, or unacceptable for testing.  

A health care provider will need to collect a new blood spot specimen from the baby. The State Laboratory will test it again.   


Parents: If your baby’s results are normal, you may not be contacted. You can ask your baby’s doctor provider about results at your baby’s two-week well child visit.  

If results are abnormal, borderline, or require a repeat screen, your baby’s doctorhealth care provider will contact you and explain next steps. In rare situations, the if the State Newborn Screening Program may contact you directly if they cannot reach your baby’s health care provider.

Providers: If the baby’s results are abnormal, borderline, or require a repeat screen, health care providers should reach out to the parents as soon as possible.

If the results are normal, the health care provider should document the results in the baby’s chart and discuss with the parents at their two-week well child visit. 

Conditions tested

To view a full list of conditions screened in North Carolina, visit: North Carolina State Newborn Screening Panel

More Resources

The Newborn Screening Information Center Newborn Screening Information Center (NBSIC) provides up-to-date information and resources about newborn screening.  

The National Organization for Rare Diseases (NORD) serves as an information hub for rare diseases. NORD provides information and other services about timely diagnosis and treatments for patients with rare diseases.  

Baby’s First Test is a resource center to educate both parents and health care professionals who are new to the newborn screening process.

The North Carolina Newborn Screening Follow-up website provides information about the condition identified through newborn screening. 

On This Page Jump Links
Off